Boston,
MA, December 4, 2003- Exergen Corporation, the
world's leading innovator of infrared medical
thermometers, announced its new promotion with
Walgreens, the nation's leading pharmacy chain,
to replace ear thermometers with Exergen's state-of-the-art
Temporal Artery Thermometers. A fast, accurate,
non-invasive method of taking temperatures by
gently scanning the forehead over the temporal
artery, studies at Boston Children's Hospital
and Harvard Medical School have proven that Exergen's
temporal artery thermometer is more accurate
than ear thermometry and more accurate than rectal
thermometer in responding to change in fever.
"Particularly due to the anticipated severity
of the flu this season, accurate and gentle non-invasive
temperatures are important. Since 90% of all
children visit the doctor because of an ear infection
by age 7, and sometimes scream at the sight of
an ear thermometer, it is important to introduce
this gentle new technology to primary care physicians.
We are pleased that Walgreens has joined us in
helping provide this same technology for consumers
at home through their over 4000 drug stores." according
to Dr. Francesco Pompei, Exergen's president.
Exergen, through its distribution partners McKesson,
Cardinal Healthcare, Physicians Sales and Service,
and other leading medical suppliers, is offering
a special promotional package to physician offices
and clinics which includes a professional model
TemporalScanner and a home model ComfortScanner
their patients can purchase at Walgreens. The
package also includes educational pamphlets with
rebate coupons for consumers, and a $50 rebate
coupon for retiring an ear thermometer at the
office or clinic.
Exergen's temporal artery
thermometers have been proven at least as accurate
as rectal measurement
and interchangeable with an esophageal probe
by studies at the Hospital for Sick Children
and the University of Toronto; as accurate as
a pulmonary artery catheter by a study at the
Massachusetts General Hospital; found to be "a
rapid, noninvasive screening tool for detection
of rectal fever" by a study by physicians
at Johns Hopkins Hospital and School of Medicine;
and found to be indispensable for pediatric practice
use in a recent 2300 patient study by Children's
Hospital Medical Center of Akron. Further descriptions
and clinical information are available from Exergen's
Medical Division. For further information on
the TAT2000C Home Model see Exergen's Consumer
Information Center.
Exergen Corporation is world leader in the science
and technology of non-invasive thermometry systems.
Developed by a team led by Dr. Pompei, who also
holds an appointment in the Dept. of Physics
at Harvard University, Exergen's temporal artery
thermometers are protected by 20 US and foreign
patents.
Visit the Exergen web
site.
Visit the Walgreens web
site.
|